Minds from medicine, engineering, and technology, united to make a difference to lives.

Former Sales Director at Endesa, Ericsson and MediaKind with 20+ years selling imaging, broadcasting, and edge computing solutions. Combined market expertise and technical knowledge now focused on transforming life sciences analysis globally.

Design professional from project phase and prototype development, to production, quality control and standards compliance.

Clinical pharmacology leader with deep experience translating complex data into safe, effective therapies for patients.

Media and technology leader specialising in strategy, generative AI, and turning innovation into measurable business impact.

Technology and product-focused professional bridging business and engineering to build scalable, data-driven solutions with sustainable, meaningful impact.
Microluma’s Scientific Advisory Board is composed of faculty members from Universidad Autónoma de Madrid (UAM), a leading public research university in Spain, under a formal collaboration agreement that supports the co-development and validation of next-generation microscopy and AI-driven analytical technologies.
The Board brings together expertise in molecular and cellular biology, oncology and translational drug discovery, with extensive experience in advanced microscopy, immunofluorescence-based cellular phenotyping, toxicological profiling and quantitative analysis of cell death and organelle dynamics.
This collaboration enables rigorous real-world scientific testing of Microluma’s beta-stage platforms within academic and translational research environments, ensuring alignment with the experimental needs of biomedical laboratories while establishing a robust framework for future Spanish and European public–private R&D funding initiatives.
Department of Biology.
Universidad Autónoma de Madrid (UAM), Spain
Expert in biomedical imaging and photodynamic therapy, specializing in cellular biology, bioenergetics and advanced fluorescence microscopy, including confocal imaging and intracellular compound localization, with experience in quantitative analysis of cell death and organelle dynamics for imaging-based technology validation.

Department of Biology.
Universidad Autónoma de Madrid (UAM), Spain
Molecular biologist and drug discovery researcher specializing in cell-based anticancer screening, assay design and mechanism-of-action studies, with expertise in biomarker-driven validation in targeted therapies and immunotherapy. Experienced in cancer biology and pharmacological research, with a strong background in pharmaceutical R&D and public–private collaboration.

Department of Biology.
Universidad Autónoma de Madrid (UAM), Spain
Expert in cellular biology and toxicology, specializing in environmental contaminants and their impact on cellular stress programs, including endoplasmic reticulum stress, mitochondrial dysfunction and DNA damage responses, with extensive experience in applied cell biology, imaging and histological analysis.
Department of Biology.
Universidad Autónoma de Madrid (UAM), Spain
Expert in cellular biology and toxicology using 2D and 3D cellular models and Drosophila systems, specializing in cell death mechanisms and comet assay–based DNA damage analysis. Her work includes evaluating the effects of environmental and dietary factors on cellular integrity and stress responses, with extensive experience in histological, embryological and imaging-based approaches for functional validation.